One billionaire valued AGO at about 3c, the next one at just above 4c, Gina valued it at 4.2c, to speed up the acquisition she improved the offer to 4.45c, with some clever conditions attached.
Recalcitrant retailers can join the bidding on Monday and increase their holdings with a view to collect profits in the future. Only Andrew can
bar Gina from ever ("ever" is realy in Andrew's hands) acquiring full ownership.
Good luck with your investment on Monday. And remember, the towel is all yours, you can always wipe off tears if things go wrong.
Gina can easily succeed in delisting AGO.
If all Market participants hold there wouldn't be any trading, liquidity would be zero and there is no need for the company to be listed.
If she waits one year simple resolution approved by the majority of shareholders is sufficient to get ASX approval to delist.
Then, there is a near certain prospect of capital raising through the rights issue, if you don't participate you get diluted. If one is married, then the partner may object to sinking more money into AGO, Part of women for woman (Gina) movemen
Every 6 months Gina can acquire 3% of issued shares under the creep acquisition rule.Another avenue is share buyback offer, to help recalcitrant shareholders in great need of money. Remember, if everyone holds the market does not function at all.
In reality, what recalcitrant shareholders decide is not causing any headaches for Gina, in this game you are powerless. Andrew is the real
stumbling block preventing Gina from 100% acquisition. This is the interesting part of the game.
- Forums
- ASX - By Stock
- AGO
- Ann: Variation of Takeover Bid
Ann: Variation of Takeover Bid, page-78
-
- There are more pages in this discussion • 180 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online